$2.7 Billion is the total value of Artal Group S.A.'s 108 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 35.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WW | WEIGHT WATCHERS INTL INC NEW | $571,245,000 | -46.5% | 14,818,300 | 0.0% | 21.16% | -23.8% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $400,000,000 | -37.8% | 60,240,864 | 0.0% | 14.82% | -11.4% | |
| GM | Buy | GENERAL MTRS COcall | $117,075,000 | +15.9% | 3,500,000 | +16.7% | 4.34% | +65.0% |
| BAC | BANK AMER CORPcall | $110,880,000 | -16.4% | 4,500,000 | 0.0% | 4.11% | +19.1% | |
| BGNE | BEIGENE LTDsponsored adr | $84,156,000 | -18.6% | 600,000 | 0.0% | 3.12% | +16.0% | |
| MRNA | New | MODERNA, INC. | $80,264,000 | – | 5,256,298 | +100.0% | 2.97% | – |
| WFC | WELLS FARGO CO NEWcall | $69,120,000 | -12.3% | 1,500,000 | 0.0% | 2.56% | +24.8% | |
| CELG | Buy | CELGENE CORPcall | $64,090,000 | -4.5% | 1,000,000 | +33.3% | 2.37% | +36.0% |
| MS | Sell | MORGAN STANLEYcall | $59,475,000 | -36.1% | 1,500,000 | -25.0% | 2.20% | -9.1% |
| BABA | Buy | ALIBABA GROUP HLDG LTDsponsored ads | $56,473,000 | +427.3% | 412,000 | +533.8% | 2.09% | +649.8% |
| SRRK | Sell | SCHOLAR ROCK HLDG CORP | $52,741,000 | -14.5% | 2,296,040 | -4.2% | 1.95% | +21.7% |
| RUBY | RUBIUS THERAPEUTICS, INC. | $46,773,000 | -33.0% | 2,908,791 | 0.0% | 1.73% | -4.6% | |
| XLRN | Buy | ACCELERON PHARMA INC | $45,728,000 | -20.1% | 1,050,000 | +5.0% | 1.69% | +13.8% |
| GS | Sell | GOLDMAN SACHS GROUP INCcall | $41,763,000 | -82.3% | 250,000 | -76.2% | 1.55% | -74.7% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $36,455,000 | -30.6% | 500,000 | -16.7% | 1.35% | -1.2% |
| NIO | Buy | NIO INCsponsored ads | $35,672,000 | +240.7% | 5,600,000 | +273.3% | 1.32% | +385.7% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $35,625,000 | +23.4% | 2,500,000 | +31.6% | 1.32% | +75.6% |
| ATRA | ATARA BIOTHERAPEUTICS INC | $34,740,000 | -16.0% | 1,000,000 | 0.0% | 1.29% | +19.6% | |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $32,346,000 | -17.1% | 600,000 | +20.0% | 1.20% | +18.0% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $28,740,000 | -40.6% | 3,000,000 | -25.0% | 1.06% | -15.4% |
| BMY | Sell | BRISTOL MYERS SQUIBB COcall | $28,589,000 | -38.6% | 550,000 | -26.7% | 1.06% | -12.6% |
| BGNE | New | BEIGENE LTDcall | $28,052,000 | – | 200,000 | +100.0% | 1.04% | – |
| FATE | Sell | FATE THERAPEUTICS INC | $27,585,000 | -22.7% | 2,150,000 | -1.8% | 1.02% | +10.1% |
| NKTR | NEKTAR THERAPEUTICS | $26,296,000 | -46.1% | 800,000 | 0.0% | 0.97% | -23.2% | |
| ARGX | Buy | ARGENX SEsponsored adr | $25,939,000 | +84.9% | 270,000 | +45.9% | 0.96% | +163.3% |
| PRQR | Buy | PROQR THRAPEUTICS N V | $22,092,000 | -12.2% | 1,400,000 | +7.7% | 0.82% | +25.1% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INCcall | $21,873,000 | +149.9% | 300,000 | +200.0% | 0.81% | +255.3% |
| FCX | Buy | FREEPORT-MCMORAN INCcall | $20,620,000 | +48.1% | 2,000,000 | +100.0% | 0.76% | +111.0% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $18,444,000 | -20.3% | 400,000 | +33.3% | 0.68% | +13.5% |
| IFRX | INFLARX NV | $18,185,000 | +6.0% | 500,000 | 0.0% | 0.67% | +51.1% | |
| XNCR | XENCOR INC | $18,080,000 | -7.2% | 500,000 | 0.0% | 0.67% | +32.1% | |
| BLUE | BLUEBIRD BIO INC | $17,360,000 | -32.1% | 175,000 | 0.0% | 0.64% | -3.3% | |
| BMRN | BIOMARIN PHARMACEUTICAL INCcall | $17,030,000 | -12.2% | 200,000 | 0.0% | 0.63% | +25.0% | |
| AUTL | Sell | AUTOLUS THERAPEUTICS PLCsponsored ads | $15,599,000 | +1.7% | 475,000 | -5.0% | 0.58% | +44.9% |
| FGEN | Buy | FIBROGEN INC | $13,884,000 | -8.6% | 300,000 | +20.0% | 0.51% | +30.1% |
| SLDB | Buy | SOLID BIOSCIENCES INC | $13,400,000 | +26.2% | 500,000 | +122.2% | 0.50% | +79.7% |
| BOLD | Buy | AUDENTES THERAPEUTICS INC | $12,792,000 | +29.2% | 600,000 | +140.0% | 0.47% | +83.7% |
| MU | MICRON TECHNOLOGY INCcall | $12,692,000 | -29.8% | 400,000 | 0.0% | 0.47% | -0.2% | |
| ALBO | ALBIREO PHARMA INC | $12,265,000 | -25.6% | 500,000 | 0.0% | 0.45% | +5.8% | |
| MDCO | MEDICINES COcall | $11,484,000 | -36.0% | 600,000 | 0.0% | 0.42% | -9.0% | |
| ALLO | New | ALLOGENE THERAPEUTICS INC | $10,772,000 | – | 400,000 | +100.0% | 0.40% | – |
| DNLI | DENALI THERAPEUTICS INC | $10,330,000 | -5.0% | 500,000 | 0.0% | 0.38% | +35.3% | |
| CMTA | Buy | CLEMENTIA PHARMACEUTICALS IN | $9,996,000 | +29.5% | 850,000 | +22.8% | 0.37% | +84.1% |
| BLUE | New | BLUEBIRD BIO INCcall | $9,920,000 | – | 100,000 | +100.0% | 0.37% | – |
| WYNN | WYNN RESORTS LTDcall | $9,891,000 | -22.2% | 100,000 | 0.0% | 0.37% | +10.6% | |
| AAL | AMERICAN AIRLS GROUP INCcall | $9,633,000 | -22.3% | 300,000 | 0.0% | 0.36% | +10.5% | |
| SAGE | SAGE THERAPEUTICS INC | $9,579,000 | -32.2% | 100,000 | 0.0% | 0.36% | -3.3% | |
| ANAB | Sell | ANAPTYSBIO INC | $9,569,000 | -68.0% | 150,000 | -50.0% | 0.35% | -54.6% |
| AGIO | New | AGIOS PHARMACEUTICALS INCcall | $9,222,000 | – | 200,000 | +100.0% | 0.34% | – |
| MLCO | New | MELCO RESORT ENTERTAINMENT Lcall | $8,810,000 | – | 500,000 | +100.0% | 0.33% | – |
| XLRN | New | ACCELERON PHARMA INCcall | $8,710,000 | – | 200,000 | +100.0% | 0.32% | – |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $7,890,000 | -26.3% | 70,000 | +40.0% | 0.29% | +4.7% |
| MDCO | MEDICINES CO | $7,656,000 | -36.0% | 400,000 | 0.0% | 0.28% | -8.7% | |
| VICI | New | VICI PPTYS INC | $7,512,000 | – | 400,000 | +100.0% | 0.28% | – |
| ZGNX | Sell | ZOGENIX INC | $7,292,000 | -63.2% | 200,000 | -50.0% | 0.27% | -47.7% |
| RGNX | Buy | REGENXBIO INC | $7,132,000 | -37.0% | 170,000 | +13.3% | 0.26% | -10.5% |
| ACIU | AC IMMUNE SA | $7,088,000 | +18.1% | 750,000 | 0.0% | 0.26% | +68.6% | |
| FGEN | New | FIBROGEN INCcall | $6,942,000 | – | 150,000 | +100.0% | 0.26% | – |
| VALE | New | VALE S Acall | $6,595,000 | – | 500,000 | +100.0% | 0.24% | – |
| NKTR | NEKTAR THERAPEUTICScall | $6,574,000 | -46.1% | 200,000 | 0.0% | 0.24% | -23.3% | |
| AGEN | AGENUS INC | $6,545,000 | +11.2% | 2,750,000 | 0.0% | 0.24% | +58.2% | |
| NIO | New | NIO INCcall | $6,370,000 | – | 1,000,000 | +100.0% | 0.24% | – |
| CRNX | CRINETICS PHARMACEUTICALS IN | $5,998,000 | +4.7% | 200,000 | 0.0% | 0.22% | +49.0% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $5,928,000 | -39.8% | 400,000 | 0.0% | 0.22% | -14.1% | |
| AXDX | ACCELERATE DIAGNOSTICS INC | $5,750,000 | -49.9% | 500,000 | 0.0% | 0.21% | -28.8% | |
| KRYS | Buy | KRYSTAL BIOTECH INC | $5,715,000 | +116.7% | 275,000 | +83.3% | 0.21% | +207.2% |
| DRNA | Buy | DICERNA PHARMACEUTICALS INC | $5,612,000 | -13.5% | 525,000 | +23.5% | 0.21% | +23.1% |
| FOLD | Sell | AMICUS THERAPEUTICS INCcall | $4,790,000 | -60.4% | 500,000 | -50.0% | 0.18% | -43.8% |
| SGMO | Buy | SANGAMO THERAPEUTICS INC | $4,592,000 | -9.7% | 400,000 | +33.3% | 0.17% | +28.8% |
| TBIO | TRANSLATE BIO INC | $4,500,000 | -25.0% | 600,000 | 0.0% | 0.17% | +7.1% | |
| REPL | REPLIMUNE GROUP INC | $4,500,000 | -37.9% | 450,000 | 0.0% | 0.17% | -11.2% | |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $4,425,000 | -43.8% | 500,000 | -28.6% | 0.16% | -20.0% |
| CRSP | Buy | CRISPR THERAPEUTICS AGnamen akt | $4,143,000 | -6.6% | 145,000 | +45.0% | 0.15% | +33.0% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $3,935,000 | -55.6% | 500,000 | -37.5% | 0.15% | -36.8% |
| STML | STEMLINE THERAPEUTICS INC | $3,800,000 | -42.8% | 400,000 | 0.0% | 0.14% | -18.5% | |
| SPRO | SPERO THERAPEUTICS INC | $3,690,000 | -41.5% | 600,000 | 0.0% | 0.14% | -16.5% | |
| CLVS | New | CLOVIS ONCOLOGY INCcall | $3,592,000 | – | 200,000 | +100.0% | 0.13% | – |
| TORC | Sell | RESTORBIO INC | $3,448,000 | -54.5% | 400,000 | -20.0% | 0.13% | -35.0% |
| ZFGN | Sell | ZAFGEN INC | $3,465,000 | -62.9% | 700,000 | -12.5% | 0.13% | -47.3% |
| TWST | New | TWIST BIOSCIENCE CORP | $3,464,000 | – | 150,000 | +100.0% | 0.13% | – |
| RCUS | ARCUS BIOSCIENCES INC | $3,231,000 | -22.7% | 300,000 | 0.0% | 0.12% | +10.1% | |
| Z | New | ZILLOW GROUP INCcl c cap stk | $3,158,000 | – | 100,000 | +100.0% | 0.12% | – |
| GRTS | GRITSTONE ONCOLOGY INC | $3,090,000 | +8.5% | 200,000 | 0.0% | 0.11% | +54.1% | |
| TCDA | Buy | TRICIDA INC | $2,948,000 | -3.5% | 125,000 | +25.0% | 0.11% | +38.0% |
| MRUS | New | MERUS N V | $2,886,000 | – | 206,125 | +100.0% | 0.11% | – |
| YI | 111 INCads | $2,763,000 | -54.6% | 450,000 | 0.0% | 0.10% | -35.4% | |
| ARPO | AERPIO PHARMACEUTICALS INC | $2,649,000 | -45.0% | 1,558,400 | 0.0% | 0.10% | -21.6% | |
| ADRO | Buy | ADURO BIOTECH INC | $2,640,000 | -34.7% | 1,000,000 | +81.8% | 0.10% | -6.7% |
| AKBA | AKEBIA THERAPEUTICS INC | $2,627,000 | -37.4% | 475,000 | 0.0% | 0.10% | -11.0% | |
| CMRX | CHIMERIX INC | $2,570,000 | -33.9% | 1,000,000 | 0.0% | 0.10% | -5.9% | |
| CTMX | New | CYTOMX THERAPEUTICS INC | $2,265,000 | – | 150,000 | +100.0% | 0.08% | – |
| FIXX | HOMOLOGY MEDICINES INC | $2,236,000 | -2.2% | 100,000 | 0.0% | 0.08% | +40.7% | |
| MNTA | New | MOMENTA PHARMACEUTICALS INC | $2,208,000 | – | 200,000 | +100.0% | 0.08% | – |
| ALDR | New | ALDER BIOPHARMACEUTICALS INC | $2,050,000 | – | 200,000 | +100.0% | 0.08% | – |
| AVRO | AVROBIO INC | $1,665,000 | -67.9% | 100,000 | 0.0% | 0.06% | -54.1% | |
| TGTX | TG THERAPEUTICS INC | $1,640,000 | -26.8% | 400,000 | 0.0% | 0.06% | +5.2% | |
| SELB | Buy | SELECTA BIOSCIENCES INC | $1,596,000 | -81.7% | 600,000 | +6.8% | 0.06% | -74.0% |
| MGEN | MIRAGEN THERAPEUTICS INC | $1,515,000 | -45.7% | 500,000 | 0.0% | 0.06% | -23.3% | |
| MRNS | MARINUS PHARMACEUTICALS INC | $1,435,000 | -71.3% | 500,000 | 0.0% | 0.05% | -59.2% | |
| MGTA | MAGENTA THERAPEUTICS INC | $1,140,000 | -52.5% | 200,000 | 0.0% | 0.04% | -32.3% | |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $1,145,000 | -43.9% | 110,532 | 0.0% | 0.04% | -20.8% | |
| YMAB | Sell | Y MABS THERAPEUTICS INC | $1,017,000 | -74.5% | 50,000 | -66.7% | 0.04% | -63.5% |
| TRILLIUM THERAPEUTICS INC | $257,000 | -70.5% | 150,000 | 0.0% | 0.01% | -56.5% | ||
| NVLNF | NOVELION THERAPEUTICS INC | $215,000 | -71.7% | 256,400 | 0.0% | 0.01% | -60.0% | |
| OCX | Exit | ONCOCYTE CORPORATION | $0 | – | -150,000 | -100.0% | -0.01% | – |
| LIFE | Exit | ATYR PHARMA INC | $0 | – | -500,000 | -100.0% | -0.01% | – |
| UBX | Exit | UNITY BIOTECHNOLOGY INC | $0 | – | -50,000 | -100.0% | -0.02% | – |
| NVAX | Exit | NOVAVAX INC | $0 | – | -500,000 | -100.0% | -0.02% | – |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -400,000 | -100.0% | -0.06% | – |
| NTLA | Exit | INTELLIA THERAPEUTICS INC | $0 | – | -90,000 | -100.0% | -0.07% | – |
| SYBX | Exit | SYNLOGIC INC | $0 | – | -200,000 | -100.0% | -0.07% | – |
| CNAT | Exit | CONATUS PHARMACEUTICALS INC | $0 | – | -500,000 | -100.0% | -0.08% | – |
| FLEX | Exit | FLEX LTDord | $0 | – | -250,000 | -100.0% | -0.08% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -250,000 | -100.0% | -0.09% | – |
| ELAN | Exit | ELANCO ANIMAL HEALTH INC | $0 | – | -100,000 | -100.0% | -0.09% | – |
| LJPC | Exit | LA JOLLA PHARMACEUTICAL CO | $0 | – | -200,000 | -100.0% | -0.10% | – |
| LOGM | Exit | LOGMEIN INC | $0 | – | -65,000 | -100.0% | -0.15% | – |
| AXDX | Exit | ACCELERATE DIAGNOSTICS INCcall | $0 | – | -500,000 | -100.0% | -0.30% | – |
| BABA | Exit | ALIBABA GROUP HLDG LTDcall | $0 | – | -100,000 | -100.0% | -0.43% | – |
| C | Exit | CITIGROUP INCcall | $0 | – | -250,000 | -100.0% | -0.47% | – |
| XBI | Exit | SPDR SERIES TRUSTcall | $0 | – | -200,000 | -100.0% | -0.50% | – |
| TSRO | Exit | TESARO INCcall | $0 | – | -500,000 | -100.0% | -0.51% | – |
| TSRO | Exit | TESARO INC | $0 | – | -800,000 | -100.0% | -0.81% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.